Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Modern Approaches in Drug Designing

Comprehensive Pharmacology of Azithromycin Repurposing for COVID-19

Submission: July 30, 2021; Published: August 05, 2021

ISSN : 2576-9170
Volume 3 Issue 3

Abstract

The theory behind the madness of azithromycin for the treatment of COVID-19 is unclear as no significant evidences are available till date. The present study aimed to discuss about the comprehensive pharmacology of azithromycin and to explore the preclinical and clinical evidences repurposing for COVID-19. Here we reviewed briefly the current knowledge about COVID-19, considering the potential explanation for the repurpose of azithromycin for this pandemic disease condition and global crisis. Azithromycin alone or in combination with Hydroxychloroquine (HCQ) modulate the anti-inflammatory processes and decreases the susceptibility to secondary bacterial pneumonia. We highlighted potential approaches to address repurpose of azithromycin for COVID-19.

Keywords: Azithromycin; Comprehensive pharmacology; Repurposing for COVID-19; Immunomodulatory activity; Combination therapy for COVID-19

Get access to the full text of this article